Article
New monogenic autoinflammatory diseases--a clinical overview.
Seminars in immunopathology - 1 Jul 2015
Canna Scott W, Goldbach-Mansky Raphaela
Abstract excerpt
Translating pathogenic insights gained from monogenic defects that cause autoinflammatory diseases into novel therapies has dramatically improved the lives of patients with these syndromes. The last 15 years have focused on the central role of IL-1 in driving autoinflammatory phenotypes and on therapies blocking IL-1 signaling. Recent discoveries from patients unresponsive to IL-1 blockade have highlighted other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
